| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cardiac Surgical Procedures | 24 | 2024 | 1164 | 6.300 |
Why?
|
| Heart Defects, Congenital | 30 | 2024 | 1782 | 5.520 |
Why?
|
| Norwood Procedures | 6 | 2023 | 101 | 3.390 |
Why?
|
| Hemodynamics | 17 | 2024 | 967 | 3.230 |
Why?
|
| Cardiac Output, Low | 5 | 2020 | 77 | 2.720 |
Why?
|
| Cardiotonic Agents | 4 | 2024 | 160 | 2.200 |
Why?
|
| Hypoplastic Left Heart Syndrome | 6 | 2023 | 253 | 1.860 |
Why?
|
| Milrinone | 2 | 2024 | 31 | 1.640 |
Why?
|
| Mucocutaneous Lymph Node Syndrome | 3 | 2023 | 76 | 1.530 |
Why?
|
| Sodium Bicarbonate | 2 | 2022 | 59 | 1.490 |
Why?
|
| Capnography | 2 | 2020 | 14 | 1.320 |
Why?
|
| Child | 53 | 2024 | 30577 | 1.320 |
Why?
|
| Heart Septal Defects, Ventricular | 2 | 2022 | 137 | 1.280 |
Why?
|
| Infant | 33 | 2024 | 13984 | 1.190 |
Why?
|
| Peritoneal Dialysis | 2 | 2020 | 140 | 1.170 |
Why?
|
| Cardiac Output | 4 | 2024 | 197 | 1.170 |
Why?
|
| Acute Kidney Injury | 4 | 2023 | 782 | 1.130 |
Why?
|
| Nicardipine | 2 | 2024 | 17 | 1.130 |
Why?
|
| Nitroprusside | 2 | 2024 | 55 | 1.120 |
Why?
|
| Oximetry | 7 | 2022 | 189 | 1.110 |
Why?
|
| Critical Care | 7 | 2023 | 811 | 1.100 |
Why?
|
| Cardiopulmonary Bypass | 6 | 2021 | 394 | 1.100 |
Why?
|
| Hospitalization | 11 | 2023 | 2183 | 1.040 |
Why?
|
| Hypertension, Pulmonary | 3 | 2020 | 470 | 1.040 |
Why?
|
| Length of Stay | 10 | 2023 | 2016 | 1.010 |
Why?
|
| Betacoronavirus | 2 | 2020 | 521 | 0.990 |
Why?
|
| Hemodynamic Monitoring | 1 | 2024 | 13 | 0.960 |
Why?
|
| Dobutamine | 1 | 2024 | 59 | 0.960 |
Why?
|
| Postoperative Period | 7 | 2022 | 671 | 0.940 |
Why?
|
| Coronavirus Infections | 3 | 2021 | 632 | 0.940 |
Why?
|
| Heart Failure, Systolic | 1 | 2024 | 34 | 0.930 |
Why?
|
| Pneumonia, Viral | 3 | 2021 | 708 | 0.930 |
Why?
|
| Point-of-Care Systems | 2 | 2023 | 215 | 0.930 |
Why?
|
| Emergency Service, Hospital | 2 | 2023 | 1243 | 0.920 |
Why?
|
| Postoperative Care | 6 | 2020 | 731 | 0.910 |
Why?
|
| Extracorporeal Membrane Oxygenation | 5 | 2023 | 638 | 0.900 |
Why?
|
| Atrioventricular Block | 1 | 2024 | 40 | 0.890 |
Why?
|
| Hepatic Veins | 1 | 2023 | 59 | 0.890 |
Why?
|
| Epinephrine | 1 | 2024 | 249 | 0.880 |
Why?
|
| Tetralogy of Fallot | 2 | 2023 | 158 | 0.870 |
Why?
|
| Vasoconstrictor Agents | 3 | 2020 | 167 | 0.830 |
Why?
|
| Blood Pressure | 8 | 2024 | 1598 | 0.820 |
Why?
|
| Humans | 93 | 2024 | 272039 | 0.810 |
Why?
|
| Infant, Newborn | 19 | 2024 | 8627 | 0.810 |
Why?
|
| Inpatients | 4 | 2023 | 695 | 0.800 |
Why?
|
| Postoperative Complications | 8 | 2024 | 5698 | 0.770 |
Why?
|
| Pacemaker, Artificial | 1 | 2024 | 206 | 0.770 |
Why?
|
| Pulmonary Surfactants | 1 | 2021 | 53 | 0.760 |
Why?
|
| Oxygen | 9 | 2023 | 800 | 0.730 |
Why?
|
| Diuretics | 2 | 2019 | 173 | 0.730 |
Why?
|
| Chylothorax | 1 | 2021 | 43 | 0.730 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2021 | 89 | 0.720 |
Why?
|
| Vascular Resistance | 3 | 2022 | 215 | 0.720 |
Why?
|
| Dexmedetomidine | 1 | 2021 | 89 | 0.720 |
Why?
|
| Intensive Care Units, Pediatric | 7 | 2024 | 477 | 0.700 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2021 | 183 | 0.690 |
Why?
|
| Fontan Procedure | 4 | 2024 | 178 | 0.690 |
Why?
|
| Pandemics | 5 | 2021 | 1605 | 0.690 |
Why?
|
| Drug Utilization | 2 | 2019 | 190 | 0.680 |
Why?
|
| Heart Arrest | 2 | 2021 | 380 | 0.680 |
Why?
|
| Practice Patterns, Physicians' | 2 | 2019 | 1324 | 0.680 |
Why?
|
| Retrospective Studies | 35 | 2024 | 39828 | 0.670 |
Why?
|
| Neutrophils | 3 | 2023 | 876 | 0.670 |
Why?
|
| Triiodothyronine | 1 | 2019 | 84 | 0.660 |
Why?
|
| Vasodilator Agents | 2 | 2024 | 234 | 0.660 |
Why?
|
| Cardiomyopathies | 2 | 2023 | 555 | 0.660 |
Why?
|
| Acidosis | 1 | 2020 | 116 | 0.660 |
Why?
|
| Respiratory Insufficiency | 1 | 2022 | 347 | 0.660 |
Why?
|
| Critical Illness | 3 | 2020 | 744 | 0.650 |
Why?
|
| Infant, Premature, Diseases | 1 | 2021 | 250 | 0.650 |
Why?
|
| Lymphocytes | 3 | 2023 | 1280 | 0.650 |
Why?
|
| Computer Simulation | 1 | 2024 | 1573 | 0.640 |
Why?
|
| Child, Preschool | 16 | 2024 | 17062 | 0.620 |
Why?
|
| Pulmonary Atresia | 3 | 2023 | 47 | 0.610 |
Why?
|
| Clinical Deterioration | 1 | 2017 | 13 | 0.600 |
Why?
|
| Lung | 2 | 2020 | 3299 | 0.600 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2020 | 566 | 0.590 |
Why?
|
| Bronchodilator Agents | 1 | 2019 | 225 | 0.580 |
Why?
|
| Multiple Organ Failure | 2 | 2023 | 177 | 0.570 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2018 | 211 | 0.570 |
Why?
|
| Hypothyroidism | 1 | 2019 | 211 | 0.570 |
Why?
|
| Hospital Rapid Response Team | 1 | 2017 | 37 | 0.570 |
Why?
|
| Hormone Replacement Therapy | 1 | 2019 | 242 | 0.550 |
Why?
|
| Nitric Oxide | 2 | 2020 | 666 | 0.540 |
Why?
|
| Heart Failure | 2 | 2021 | 2381 | 0.540 |
Why?
|
| Coronary Vessel Anomalies | 2 | 2020 | 271 | 0.530 |
Why?
|
| Cause of Death | 1 | 2019 | 785 | 0.520 |
Why?
|
| Familial Primary Pulmonary Hypertension | 1 | 2015 | 20 | 0.510 |
Why?
|
| Scimitar Syndrome | 1 | 2016 | 53 | 0.500 |
Why?
|
| Anesthesia | 1 | 2018 | 306 | 0.490 |
Why?
|
| Aortic Coarctation | 1 | 2016 | 105 | 0.480 |
Why?
|
| Ketamine | 1 | 2018 | 243 | 0.480 |
Why?
|
| Treatment Outcome | 19 | 2024 | 33913 | 0.470 |
Why?
|
| Hypotension | 3 | 2022 | 237 | 0.470 |
Why?
|
| Pulmonary Veins | 1 | 2016 | 181 | 0.460 |
Why?
|
| Vena Cava, Superior | 2 | 2021 | 78 | 0.450 |
Why?
|
| Echocardiography | 5 | 2023 | 1238 | 0.440 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2015 | 250 | 0.440 |
Why?
|
| Heart | 3 | 2023 | 1211 | 0.440 |
Why?
|
| Ventricular Septum | 2 | 2022 | 17 | 0.420 |
Why?
|
| Lactates | 2 | 2022 | 123 | 0.410 |
Why?
|
| Gases | 2 | 2022 | 39 | 0.400 |
Why?
|
| Aneurysm | 1 | 2012 | 91 | 0.400 |
Why?
|
| Systemic Inflammatory Response Syndrome | 3 | 2022 | 194 | 0.400 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2015 | 338 | 0.390 |
Why?
|
| Hospital Mortality | 4 | 2022 | 1317 | 0.380 |
Why?
|
| Aorta, Thoracic | 1 | 2016 | 532 | 0.380 |
Why?
|
| Intensive Care Units | 5 | 2022 | 745 | 0.370 |
Why?
|
| Leukocyte Count | 3 | 2021 | 738 | 0.370 |
Why?
|
| Cross-Sectional Studies | 7 | 2023 | 4512 | 0.340 |
Why?
|
| Hypertension | 2 | 2020 | 1621 | 0.340 |
Why?
|
| Risk Factors | 10 | 2023 | 18024 | 0.330 |
Why?
|
| C-Reactive Protein | 3 | 2021 | 565 | 0.330 |
Why?
|
| Disease Management | 1 | 2015 | 1111 | 0.330 |
Why?
|
| Heart Ventricles | 4 | 2023 | 847 | 0.320 |
Why?
|
| Preoperative Period | 2 | 2020 | 349 | 0.310 |
Why?
|
| Male | 24 | 2024 | 129081 | 0.300 |
Why?
|
| Female | 25 | 2024 | 149291 | 0.290 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2012 | 920 | 0.280 |
Why?
|
| Vasopressins | 3 | 2021 | 64 | 0.280 |
Why?
|
| Biomarkers | 3 | 2023 | 5098 | 0.270 |
Why?
|
| Cardiology | 2 | 2022 | 552 | 0.260 |
Why?
|
| Sepsis | 2 | 2022 | 689 | 0.260 |
Why?
|
| Heart Valve Diseases | 2 | 2019 | 196 | 0.250 |
Why?
|
| Adolescent | 8 | 2024 | 32759 | 0.250 |
Why?
|
| Carbon Dioxide | 3 | 2022 | 331 | 0.250 |
Why?
|
| Respiration, Artificial | 4 | 2024 | 583 | 0.250 |
Why?
|
| Pulmonary Artery | 4 | 2023 | 521 | 0.240 |
Why?
|
| Stroke | 2 | 2023 | 1096 | 0.240 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2022 | 2674 | 0.240 |
Why?
|
| Stroke Volume | 2 | 2024 | 552 | 0.240 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2023 | 173 | 0.230 |
Why?
|
| Norepinephrine | 1 | 2024 | 284 | 0.220 |
Why?
|
| Tidal Volume | 2 | 2020 | 58 | 0.220 |
Why?
|
| Blood Gas Analysis | 2 | 2021 | 106 | 0.220 |
Why?
|
| Age Factors | 4 | 2021 | 5519 | 0.210 |
Why?
|
| Vena Cava, Inferior | 1 | 2024 | 195 | 0.210 |
Why?
|
| Dopamine | 1 | 2024 | 339 | 0.210 |
Why?
|
| Competency-Based Education | 1 | 2023 | 81 | 0.210 |
Why?
|
| Prospective Studies | 5 | 2021 | 13404 | 0.210 |
Why?
|
| Databases, Factual | 2 | 2020 | 2289 | 0.200 |
Why?
|
| Bicarbonates | 1 | 2022 | 114 | 0.200 |
Why?
|
| Ultrasonography | 3 | 2023 | 1941 | 0.200 |
Why?
|
| Steroids | 1 | 2024 | 375 | 0.200 |
Why?
|
| Cardiovascular System | 1 | 2023 | 147 | 0.200 |
Why?
|
| Administration, Inhalation | 2 | 2020 | 299 | 0.200 |
Why?
|
| Airway Extubation | 1 | 2022 | 74 | 0.200 |
Why?
|
| Follow-Up Studies | 5 | 2020 | 15273 | 0.190 |
Why?
|
| Surface-Active Agents | 1 | 2021 | 41 | 0.190 |
Why?
|
| Adrenergic alpha-2 Receptor Agonists | 1 | 2021 | 33 | 0.190 |
Why?
|
| Coronary Stenosis | 1 | 2022 | 93 | 0.190 |
Why?
|
| Bayes Theorem | 2 | 2024 | 1056 | 0.190 |
Why?
|
| Tracheostomy | 1 | 2024 | 247 | 0.190 |
Why?
|
| Thoracic Duct | 1 | 2021 | 13 | 0.190 |
Why?
|
| Dialysis | 1 | 2021 | 25 | 0.190 |
Why?
|
| Shock, Cardiogenic | 1 | 2023 | 238 | 0.190 |
Why?
|
| Antihypertensive Agents | 1 | 2024 | 442 | 0.190 |
Why?
|
| Fluid Therapy | 1 | 2022 | 196 | 0.190 |
Why?
|
| Bland White Garland Syndrome | 1 | 2020 | 1 | 0.190 |
Why?
|
| Pleurodesis | 1 | 2021 | 70 | 0.180 |
Why?
|
| Ligation | 1 | 2021 | 208 | 0.180 |
Why?
|
| Japan | 1 | 2020 | 237 | 0.180 |
Why?
|
| Biliary Atresia | 1 | 2023 | 201 | 0.180 |
Why?
|
| Infusions, Intravenous | 2 | 2020 | 1438 | 0.180 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2021 | 207 | 0.180 |
Why?
|
| Antithrombins | 1 | 2020 | 62 | 0.180 |
Why?
|
| Malnutrition | 1 | 2023 | 225 | 0.170 |
Why?
|
| Interactive Ventilatory Support | 1 | 2019 | 1 | 0.170 |
Why?
|
| Time Factors | 5 | 2020 | 13135 | 0.170 |
Why?
|
| Erythrocyte Transfusion | 1 | 2021 | 211 | 0.170 |
Why?
|
| Hypnotics and Sedatives | 1 | 2021 | 220 | 0.170 |
Why?
|
| Heart Septal Defects | 1 | 2019 | 49 | 0.170 |
Why?
|
| Noonan Syndrome | 1 | 2019 | 29 | 0.170 |
Why?
|
| Cardiomyopathy, Hypertrophic | 1 | 2021 | 172 | 0.160 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2020 | 622 | 0.160 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 1 | 2020 | 250 | 0.160 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2021 | 322 | 0.160 |
Why?
|
| Drug Therapy, Combination | 1 | 2024 | 2365 | 0.160 |
Why?
|
| Virus Diseases | 1 | 2022 | 392 | 0.160 |
Why?
|
| Anesthetics, Dissociative | 1 | 2018 | 23 | 0.160 |
Why?
|
| Case-Control Studies | 2 | 2019 | 6233 | 0.160 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2023 | 360 | 0.160 |
Why?
|
| Heterotaxy Syndrome | 1 | 2019 | 63 | 0.160 |
Why?
|
| Thyroxine | 1 | 2018 | 117 | 0.150 |
Why?
|
| Patient Admission | 1 | 2019 | 236 | 0.150 |
Why?
|
| Cerebrovascular Circulation | 1 | 2021 | 515 | 0.150 |
Why?
|
| Risk Assessment | 2 | 2021 | 6882 | 0.150 |
Why?
|
| Methylprednisolone | 1 | 2018 | 200 | 0.150 |
Why?
|
| Diagnosis, Differential | 2 | 2020 | 4899 | 0.150 |
Why?
|
| Water-Electrolyte Balance | 1 | 2017 | 101 | 0.140 |
Why?
|
| Venous Thrombosis | 1 | 2021 | 381 | 0.140 |
Why?
|
| Hydrocortisone | 1 | 2018 | 406 | 0.140 |
Why?
|
| Periodicals as Topic | 1 | 2021 | 324 | 0.140 |
Why?
|
| Ventricular Dysfunction | 1 | 2016 | 33 | 0.140 |
Why?
|
| Arginine Vasopressin | 1 | 2016 | 66 | 0.140 |
Why?
|
| Parents | 1 | 2023 | 1078 | 0.140 |
Why?
|
| Heart Transplantation | 1 | 2023 | 901 | 0.130 |
Why?
|
| Early Diagnosis | 1 | 2017 | 316 | 0.130 |
Why?
|
| Pneumonia | 1 | 2022 | 798 | 0.130 |
Why?
|
| Ventricular Function | 1 | 2016 | 100 | 0.130 |
Why?
|
| Health Care Surveys | 1 | 2017 | 425 | 0.130 |
Why?
|
| Triage | 1 | 2017 | 258 | 0.130 |
Why?
|
| Recovery of Function | 1 | 2019 | 690 | 0.130 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 943 | 0.130 |
Why?
|
| Echocardiography, Doppler, Color | 1 | 2015 | 122 | 0.130 |
Why?
|
| Resuscitation | 1 | 2017 | 271 | 0.120 |
Why?
|
| Reoperation | 1 | 2019 | 1393 | 0.120 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2015 | 219 | 0.120 |
Why?
|
| Glucocorticoids | 1 | 2018 | 623 | 0.120 |
Why?
|
| Proportional Hazards Models | 2 | 2024 | 5112 | 0.120 |
Why?
|
| Dietary Supplements | 1 | 2018 | 560 | 0.120 |
Why?
|
| Body Weight | 1 | 2019 | 1335 | 0.110 |
Why?
|
| United States | 3 | 2021 | 16033 | 0.110 |
Why?
|
| Heart-Assist Devices | 1 | 2022 | 1050 | 0.110 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2014 | 235 | 0.110 |
Why?
|
| Coronary Angiography | 1 | 2015 | 567 | 0.110 |
Why?
|
| Kidney | 1 | 2021 | 2263 | 0.100 |
Why?
|
| Double-Blind Method | 1 | 2018 | 2610 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2018 | 3078 | 0.100 |
Why?
|
| Registries | 1 | 2019 | 2247 | 0.090 |
Why?
|
| Inflammation | 1 | 2020 | 2533 | 0.090 |
Why?
|
| Attitude of Health Personnel | 1 | 2017 | 920 | 0.090 |
Why?
|
| Prognosis | 2 | 2020 | 22543 | 0.090 |
Why?
|
| Cardiac Catheterization | 1 | 2015 | 692 | 0.090 |
Why?
|
| Palliative Care | 1 | 2022 | 2171 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 2 | 2022 | 564 | 0.090 |
Why?
|
| Incidence | 1 | 2021 | 5859 | 0.090 |
Why?
|
| Heart Valve Prosthesis Implantation | 1 | 2014 | 485 | 0.080 |
Why?
|
| Heart Rate | 2 | 2023 | 757 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 6275 | 0.080 |
Why?
|
| ROC Curve | 2 | 2023 | 1246 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2019 | 9318 | 0.070 |
Why?
|
| Combined Modality Therapy | 1 | 2017 | 9050 | 0.070 |
Why?
|
| Adult | 3 | 2023 | 81993 | 0.060 |
Why?
|
| Glasgow Coma Scale | 1 | 2023 | 218 | 0.050 |
Why?
|
| Central Venous Pressure | 1 | 2022 | 27 | 0.050 |
Why?
|
| Immunoglobulins, Intravenous | 1 | 2023 | 192 | 0.050 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2023 | 98 | 0.050 |
Why?
|
| Sample Size | 1 | 2022 | 214 | 0.050 |
Why?
|
| Phentolamine | 1 | 2021 | 28 | 0.050 |
Why?
|
| Calcium Chloride | 1 | 2021 | 26 | 0.050 |
Why?
|
| Mediastinum | 1 | 2023 | 278 | 0.050 |
Why?
|
| GTP-Binding Proteins | 1 | 2023 | 347 | 0.050 |
Why?
|
| Middle Aged | 3 | 2023 | 90457 | 0.050 |
Why?
|
| Bile Acids and Salts | 1 | 2023 | 261 | 0.050 |
Why?
|
| Seasons | 1 | 2022 | 337 | 0.050 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2021 | 66 | 0.050 |
Why?
|
| Calcitonin | 1 | 2021 | 181 | 0.050 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2021 | 168 | 0.050 |
Why?
|
| Nutritional Status | 1 | 2023 | 354 | 0.050 |
Why?
|
| Albumins | 1 | 2022 | 267 | 0.050 |
Why?
|
| Bibliometrics | 1 | 2021 | 69 | 0.040 |
Why?
|
| Protein Precursors | 1 | 2021 | 250 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2015 | 7792 | 0.040 |
Why?
|
| Residence Characteristics | 1 | 2022 | 360 | 0.040 |
Why?
|
| Hemoglobins | 1 | 2021 | 485 | 0.040 |
Why?
|
| Arterial Pressure | 1 | 2020 | 106 | 0.040 |
Why?
|
| Lymphocyte Count | 1 | 2021 | 485 | 0.040 |
Why?
|
| Wisconsin | 1 | 2019 | 27 | 0.040 |
Why?
|
| Pregnancy | 1 | 2012 | 8112 | 0.040 |
Why?
|
| Publishing | 1 | 2021 | 196 | 0.040 |
Why?
|
| Lactic Acid | 1 | 2020 | 312 | 0.040 |
Why?
|
| Hypoxia | 1 | 2021 | 477 | 0.040 |
Why?
|
| Chest Tubes | 1 | 2019 | 118 | 0.040 |
Why?
|
| Mitral Valve Insufficiency | 1 | 2020 | 189 | 0.040 |
Why?
|
| Heparin | 1 | 2020 | 346 | 0.040 |
Why?
|
| Respiratory Function Tests | 1 | 2019 | 355 | 0.040 |
Why?
|
| Arginine | 1 | 2021 | 510 | 0.040 |
Why?
|
| Diaphragm | 1 | 2019 | 187 | 0.040 |
Why?
|
| Respiration | 1 | 2019 | 465 | 0.030 |
Why?
|
| Down Syndrome | 1 | 2019 | 227 | 0.030 |
Why?
|
| Logistic Models | 1 | 2023 | 3464 | 0.030 |
Why?
|
| Healthcare Disparities | 1 | 2021 | 658 | 0.030 |
Why?
|
| Liver Cirrhosis | 1 | 2023 | 1033 | 0.030 |
Why?
|
| Comorbidity | 1 | 2021 | 2428 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2020 | 790 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2023 | 4993 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 6208 | 0.030 |
Why?
|
| Aged | 2 | 2021 | 73500 | 0.010 |
Why?
|